The aim is to ensure that the benefit of tax cuts is passed on to consumers, in line with the Drugs (Prices Control) Order, which mandates that MRP of medicines are inclusive of all applicable taxes. It also clarified that recall, re-labelling, or re-stickering of unsold/released stock is not mandatory, but may be undertaken voluntarily by manufacturers subject to compliance with certain conditions.